BNB Token Treasury Company Windtrree is removed from Nasdaq

The healthcare -oriented company will trade its shares on the Nasdaq by the end of the week, because the strategy of the Treasury has not produced any results comparable to those of its colleagues in the industry.

In the same way, the shares of the strategy have also experienced some jitters, albeit not so pronounced because of other factors.

Unfortunate turn of events

In surprise submit To the Securities and Exchange Commission (SEC), Windtrree Therapeutics (Ticker: wins), an American company for drug development for patients with respiratory diseases, will be removed from the Nasdaq grant index for non -compliance with the regulations.

In particular, it has not met the requirement of a frame line, which states that a company stated on the index must maintain a minimum price of $ 1.00 per share. The CEO of the company, Jed Latkin, noted the following in the 8-K form:

“On August 19, 2025, Windtree Therapeutics Inc. (the” company “) was informed by the Nasdaq Stock Market LLC (” Nasdaq “) that, as a result of the previously announced non -announcement of the company with Nasdaq Listing Rule 5550 (A) (2).

NASDAQ has decided to remove the ordinary shares of the company from the Nasdaq capital market and will be in accordance with the trade in the ordinary shares of the company on August 21, 2025 of the trade. “

It was just over a month ago that the company announced It would take over the BNB Munt as part of a strategic reserve, with an initial investment of $ 60 million from Build and Build Corp. and an extra $ 140 million Expected from further subscriptions.

The organization searched within the same month An extra $ 520 million in financing via a normal sharing purchase agreement for a credit line of a maximum of $ 500 million, as well as a separate stock purchase of $ 20 million with build and Build.

Data taken at the time of writing indicate that the shares of the company fell sharply most of the year, a decrease of more than 97% in the last six months, with only a slight increase from $ 0.90 to $ 1.19 in the two days after the news that it had adopted a crypto -outskist strategy.

At this stage it is unclear what investors have made so much, because the underlying asset of choice for the treasury has performed exceptionally well this year. At the time of printing, BNB acts around $ 850, an increase of 2.5% for the day and more than 53% for the year, according to data from Coinmarketcap.

Is the Treasury trend not paid off?

Windtree Therapeutics is not the only treasury company that has recently seen its shares, because the Michael Saylor-Found strategy has also decreased somewhat this week.

The share is currently being traded around $ 344, according to Google Finance a decrease in the past five days by 9%. Yet this is nothing compared to the increase of 143% compared to last year and the increase of more than 2,200% compared to the previous five years.

The light drop is probably connected to Saylor’s after On X from Monday, when he revealed that the company will change its guidelines for Equity ATM (on the market), which meant that it will lower the threshold for selling shares to finance more Bitcoin purchases.

Before these changes, the company’s policy was not to issue new shares under 2.5 times its market NAV (market value shared by Bitcoin Holdings), unless it was strict to cover interest on debts or for dividend payments.

Now that the 2.5 threshold has been reduced, shares can be spent at lower costs, which increases the flexibility for business needs, but also makes it more risky for shareholders.